SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009707
Filing Date
2023-05-15
Accepted
2023-05-15 09:27:55
Documents
109
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20230331x10q.htm   iXBRL 10-Q 2486705
2 EX-10.7 ibio-20230331xex10d7.htm EX-10.7 2420173
3 EX-10.8 ibio-20230331xex10d8.htm EX-10.8 59407
4 EX-31.1 ibio-20230331xex31d1.htm EX-31.1 18443
5 EX-31.2 ibio-20230331xex31d2.htm EX-31.2 18796
6 EX-32.1 ibio-20230331xex32d1.htm EX-32.1 10606
7 EX-32.2 ibio-20230331xex32d2.htm EX-32.2 6730
8 GRAPHIC ibio-20230331x10q001.jpg GRAPHIC 79971
9 GRAPHIC ibio-20230331x10q002.jpg GRAPHIC 84811
10 GRAPHIC ibio-20230331xex10d7001.jpg GRAPHIC 5158
  Complete submission text file 0001558370-23-009707.txt   14421616

Data Files

Seq Description Document Type Size
11 EX-101.SCH ibio-20230331.xsd EX-101.SCH 103141
12 EX-101.CAL ibio-20230331_cal.xml EX-101.CAL 96217
13 EX-101.DEF ibio-20230331_def.xml EX-101.DEF 307867
14 EX-101.LAB ibio-20230331_lab.xml EX-101.LAB 635190
15 EX-101.PRE ibio-20230331_pre.xml EX-101.PRE 586628
103 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20230331x10q_htm.xml XML 2108382
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 23919012
SIC: 2834 Pharmaceutical Preparations